Acid-base status in dietary treatment of phenylketonuria.
Blood acid-base status, serum electrolytes, and urine pH were examined in 64 infants and children with phenylketonuria (PKU) treated with three different low phenylalanine protein hydrolyzates (Aponti, Cymogran, AlbumaidXP) and two synthetic amino acid mixtures (Aminogran, PAM). The formulas caused significant differences in acid-base status, serum potassium, and chloride, and in urine pH. In acid-base balance studies in two patients with PKU, Aponti, PAM, and two modifications of PAM (P2 + P3) were given. We observed a change from mild alkalosis to increasing metabolic acidosis from Aponti (serum bicarbonate 25,8 mval/liter) to P3 (24,0Y, P2 (19, 3) and PAM (17,0). Urine pH decreased and renal net acid excretion increased. In the formulas PAM, P2 and P3 differences in renal net acid excretion correlated with differences in chloride and sulfur contents of the diets and of the urines. New modifications of AlbumaidXP and of PAM, prepared according to our recommendations, showed normal renal net acid excretion (1 mEq/kg/24 hr) in a balance study performed in one patient with PKU and normal acid base status in 20 further patients.
D000136:Acid-Base Equilibrium; D000596:Amino Acids / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004573:Electrolytes / Q000097:blood; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010661:Phenylketonurias / Q000178:diet therapy* / Q000378:metabolism; D011492:Protein Hydrolysates / Q000627:therapeutic use
D000596:Amino Acids; D004573:Electrolytes; D011492:Protein Hydrolysates